整合遗传学分析:精准精神病学的基石
本文综述了神经发育与精神障碍(NPD)遗传检测从提供病因解释向在症状出现前识别高危个体的转变,指出全外显子或基因组测序在新生儿和产前常规诊断中的系统应用推动了这一转变,并讨论了优化个体风险预测作为精准医学关键前提所需的技术与统计方法。
要点
- 遗传检测在NPD领域正从解释已发症状转向预测症状出现前的个体风险。
- 全外显子或基因组测序纳入新生儿和产前常规诊断是这一转变的推动因素。
- 个体风险预测的优化是NPD精准医学的关键前提,需相应技术与统计方法。
核心结论
- 优化个体风险预测是NPD领域精准医学的关键前提,并需相应技术与统计方法。
研究设计与样本
- 综述,检索范围未报告。
主要发现
- 遗传检测在NPD领域正从提供病因解释转向识别临床显现前的高风险年轻个体。
- 全外显子或基因组测序在新生儿和产前常规诊断中的系统实施推动了从回顾性解释向先验性风险预测的转变。
- 遗传检测在发育早期的快速普及使个体因NPD遗传易感性而在症状出现前就诊。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The role of genetic testing in the domain of neurodevelopmental and psychiatric disorders (NPDs) is gradually changing from providing etiological explanation for the presence of NPD phenotypes to also identifying young individuals at high risk of developing NPDs before their clinical manifestation. In clinical practice, the latter implies a shift towards the availability of individual genetic information predicting a certain liability to develop an NPD (e.g., autism, intellectual disability, psychosis etc.). The shift from mostly a posteriori explanation to increasingly a priori risk prediction is the by-product of the systematic implementation of whole exome or genome sequencing as part of routine diagnostic work-ups during the neonatal and prenatal periods. This rapid uptake of genetic testing early in development has far-reaching consequences for psychiatry: Whereas until recently individuals would come to medical attention because of signs of abnormal developmental and/or behavioral symptoms, increasingly, individuals are presented based on genetic liability for NPD outcomes before NPD symptoms emerge. This novel clinical scenario, while challenging, also creates opportunities for research on prevention interventions and precision medicine approaches. Here, we review why optimization of individual risk prediction is a key prerequisite for precision medicine in the sphere of NPDs, as well as the technological and statistical methods required to achieve this ambition.
引用
- Vorstman J, Sebat J, Bourque VR, et al. Integrative genetic analysis: cornerstone of precision psychiatry. Mol Psychiatry. 2024. PMID: 39215185. doi:10.1038/s41380-024-02706-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。